Highlights and Quick Summary
Current EV/FCF of Orgenesis Inc. is -2.19 (as of December 31, 2021)
- EV/FCF for the quarter ending March 31, 2022 was -2.93 (a 33.91% increase compared to previous quarter)
- Year-over-year quarterly EV/FCF increased by 100.11%
- Annual EV/FCF for 2021 was -2.19 (a 181.74% increase from previous year)
- Annual EV/FCF for 2020 was -0.78 (a -77.33% decrease from previous year)
- Annual EV/FCF for 2019 was -3.42 (a 50.07% increase from previous year)
Visit stockrow.com/ORGS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EV/FCF of Orgenesis Inc.
Most recent EV/FCFof ORGS including historical data for past 10 years.Interactive Chart of EV/FCF of Orgenesis Inc.
Orgenesis Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | -2.93 | – | – | – | – |
2021 | -2.19 | -1.57 | -1.46 | -1.54 | -2.19 |
2020 | -0.78 | -0.77 | -1.14 | 0.84 | -0.78 |
2019 | -3.42 | -3.21 | -2.59 | -2.75 | -3.42 |
2018 | -2.28 | -4.11 | -5.61 | -12.77 | -2.28 |
2017 | – | -12.05 | -8.01 | -27.93 | -15.04 |
2016 | -15.48 | -7.59 | -5.49 | -1.21 | -15.48 |
2015 | – | – | – | – | 0.0 |
Business Profile of Orgenesis Inc.
Sector: Healthcare
Industry: Biotechnology